Publication & Citation Trends
Publications
0 total
Comprehensive analysis of an ATF/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study
Cited by 1
Semantic Scholar
The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
Cited by 0
Semantic Scholar
Outcomes and prognostic factors of first-line combination of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) in TFE3-rearranged renal cell carcinoma.
Cited by 1
Semantic Scholar
Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer OA
Cited by 0
Semantic Scholar
PD24-09 PHASE II, MULTI-CENTER STUDY OF SINTILIMAB IN COMBINATION WITH AXITINIB IN PATIENTS WITH ADVANCED FUMARATE HYDRATASE-DEFICIENT RENAL CELL CARCINOMA
Cited by 0
Semantic Scholar
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer
Cited by 4
Semantic Scholar
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients OA
Cited by 15
Semantic Scholar
Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients OA
Cited by 5
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(90)
Epigenetics and DNA Methylation
(47)
Prostate Cancer Treatment and Research
(45)
Phagocytosis and Immune Regulation
(26)
Prostate Cancer Diagnosis and Treatment
(21)
Affiliations
Huaqiao University
Tianjin University of Traditional Chinese Medicine
Shenyang Aerospace University
Zhejiang A & F University
National Bureau of Statistics of China